Shows / The HemOnc Pulse

The HemOnc Pulse
Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.
The show, from its episodes
No episode notes yet. Recurring topics, people and starter picks will appear when notes are available.
Typical episode length
27m · median of 89 episodes with a known length
Solo / guest format
Unknown — existing notes name people mentioned, but do not identify hosts or guests.
Recurring topics
No recurring topics established yet.
Recurring people
No recurring people established yet.
Start here
No starter picks yet — no published episodes with audio and a recorded notes hook.
Episodes
The HemOnc PulsePutting AI to Work in Blood Cancer Clinical Trials
The HemOnc Pulse host, Rahul Banerjee, MD, of Fred Hutchinson Cancer Center, returns for Part 2 of a conversation on the evolving role of AI in hematologic…
The HemOnc PulseThe Transformative Potential of AI in Hematologic Malignancies
How is AI transforming hematologic cancer care? In this episode of The HemOnc Pulse, Rahul Banerjee, MD, of the Fred Hutchinson Cancer Institute, interviews…
The HemOnc PulseRewriting the Treatment Playbook for MDS/MPN and Myelofibrosis
In this Editor’s Special episode of The HemOnc Pulse, MD Anderson Cancer Center’s Naval Daver, MD, and Naveen Pemmaraju, MD, discuss MDS/MPN overlap conditions…
The HemOnc PulseTaking Bispecific Antibodies Outpatient: Lessons From the Front Lines
How can bispecific antibodies be safely delivered outside the hospital? Rahul Banerjee, MD and Ajay Nooka, MD discuss outpatient step-up dosing, prophylactic…
The HemOnc PulseCommunity-Based CAR-T Therapy: Expanding Access, Navigating Challenges
In this episode of HemOnc Pulse, host Dr. Rahul Banerjee of Fred Hutchinson Cancer Center sits down with Dr. Gary Simmons, a hematologist-oncologist at…
The HemOnc PulseCutting GVHD Risk: What’s Changing in Allogeneic Transplants?
Learn how new approaches in allogeneic transplants, from PTCy to innovative regimens, are helping reduce GVHD and improve patient outcomes with special guest…
The HemOnc PulseMRD at the Regulatory Crossroads in Multiple Myeloma
In this Editor’s Special Episode of The HemOncPulse, a conversation with Nicholas Richardson, DO, MPH, vice president of clinical development at Precision for…
The HemOnc PulseThe Data Problem in T-Cell Lymphoma Care
In this episode of TheHemOnc Pulse, Rahul Banerjee, MD, speaks with Francine Foss, MD, professor of medicine and dermatology at Yale School of Medicine, about…
The HemOnc PulseXPO1 Inhibition Across the Myeloma Journey
This Editor’s Special Episode of The HemOnc Pulse features Paul G. Richardson, MD, of Dana-Farber Cancer Institute, discussing treatment strategies for…
The HemOnc PulseHolding the Line in AML: Real-World Care Meets Breakthrough Trials
Dr. Eunice Wang joins host Rahul Banerjee, MD, for a clinician-focused discussion on AML, treatment complexity, and real-world leukemia management in today’s…
The HemOnc PulseUnder the Hood: Exploring the Genomic Engines of Smoldering Myeloma
In this episode of The HemOnc Pulse, host Melissa speaks with Omar Nadeem, MD, Senior Physician at Dana-Farber Cancer Institute and Assistant Professor of…
The HemOnc PulseToxicity, Time, and the Patient Experience in Blood Cancers
Dr. Rahul Banerjee interviews Dr. Ajay Major on patient-reported outcomes, toxicity reporting, and patient engagement in blood cancer clinical trials.
The HemOnc PulseEditor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs
Dr. Hobbs joins the podcast to discuss the latest advances in myeloproliferative neoplasms (MPNs), including ropeginterferon and the VERIFY trial of rusfertide…
The HemOnc PulseClinical Advances in Myeloma: A Nordic Perspective
Host Rahul Banerjee, MD, speaks with Drs. Frederik Schjesvold and Frida Askeland on myeloma trial results, relevance in the IMROZ/CEPHEUS era, and advances in…
The HemOnc PulseGrand Rounds in Leukemia: MD Anderson Fellows on AML Endpoints
MD Anderson fellows discuss AML, MRD endpoints, and evolving trial strategies in a dynamic grand rounds–style presentation.
The HemOnc PulseEditor’s Special Episode: Progress and Prospects in CLL Management
William Wierda, MD, PhD of the University of Texas MD Anderson discusses advances in chronic lymphocytic leukemia care, from targeted therapies and resistance…
The HemOnc PulseToday’s Clinical Trials Define the Next Era in Myeloma
In this Editor’s Special Episode of The HemOnc Pulse, Dr. Hira Mian of McMaster University shares expert insights on the evolving treatment landscape for…
The HemOnc Pulse‘The HemOnc Pulse Live:’ Transforming ALL Treatment Pathways
A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging…
The HemOnc PulseEvolving Approaches in the Management of MDS
Review of IMerge phase 3 data on imetelstat for lower-risk MDS and how prior therapies affect treatment outcomes, and other ASCO 2025 MDS updates with Andrew…
The HemOnc Pulse‘The HemOnc Pulse Live!’: AML in Transition
During a session at The HemOnc Pulse Live! moderated by Naval Daver, MD, Eunice Wang, MD presents new insights in acute myeloid leukemia care, joined by Aditi…
The HemOnc PulseFrom Trials to Practice: What's New and What's Next for Myeloma
Drs. Gurbakhash Kaur and Danai Dima discuss next-gen CAR T and bispecific therapies for myeloma, including agents for extramedullary disease and GPRC5D targets.
The HemOnc PulseEditor’s Special Episode: Innovations in B-NHL
In this Editor’s Special of The HemOnc Pulse, Tycel Phillips, MD, joins an editor of Blood Cancers Today to break down the latest research in B-cell…
The HemOnc PulseEditor’s Special Episode: Treating CLL Now and in the Future
Hematologist-oncologist Dr. Alexey Danilov shares expert insights on chronic lymphocytic leukemia, highlighting unmet needs in immune management, the…
The HemOnc Pulse'The HemOnc Pulse Live': Controversies in Frontline Myeloma
Saad Usmani, MD, MBA leads an in-depth discussion with a panel of leading myeloma experts; Dr. Caitlin Costello, Dr. Binod Dhakal, Dr. Pete Voorhees, and Dr…
The HemOnc PulseEditor’s Special Episode: ASCO 2025 Highlights in AML with Dr. Amir Fathi
In this Editor’s Special of The HemOnc Pulse, Blood Cancers Today Managing Editor, Nichole Tucker speaks with Amir Fathi, MD, of Massachusetts General…
The HemOnc PulseNavigating Drug Accessibility in Cancer Care
In this episode of The Hem Onc Pulse, Dr. Rahul Banerjee is joined by Dr. Michelle Longmire, CEO and co-founder of Medable, for a compelling discussion on drug…
The HemOnc PulseThe 'HemOnc Pulse Live' Controversies in Aggressive NHL
In this HemOnc Pulse Live! edition of podcast, Dr. Mehdi Hamadani leads a comprehensive panel discussion on controversies and unanswered questions in the…
The HemOnc PulseInside the War on Myeloid Malignancies: Early Clues & Bold Innovations
In this episode of HemOnc Pulse, host Rahul Banerjee, MD, FACP of Fred Hutch Cancer Center is joined by myeloid malignancy expert Uma Borate, MBBS of The Ohio…
The HemOnc Pulse'The HemOnc Pulse' Live 2025: Controversies in MDS
In this special episode of our podcast, recorded live at HemOnc Pulse Live in Austin, Texas on May 2–3, 2025, leading experts tackle some of the most pressing…
The HemOnc PulseRedirected Strategy: Tal and TEC in the Myeloma Mix
In this episode of The HemOnc Pulse, Rahul Banerjee, MD of Fred Hutchinson Cancer Center is joined by Gurbakhash Kaur, MD of Mount Sinai for an in-depth…
The HemOnc PulseDr. Usmani Highlights Myeloma Presentations from SOHO 2024
On this episode of "The HemOnc Pulse," Saad Usmani, MD, of the Memorial Sloan Kettering Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss notable…
The HemOnc PulseCovering MDS Updates at SOHO 2024 With Dr. Venugopal
On this episode of "The HemOnc Pulse," Chadi Nabhan, MD, MBA, FACP, is joined by Sangeetha Venugopal, MD, of the Sylvester Comprehensive Cancer Center at the…
The HemOnc PulseAML News From SOHO 2024 With Dr. Daver
On this episode of "The HemOnc Pulse," Naval Daver, MD, of the MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss news on acute myeloid…
The HemOnc PulseDr. Shadman Shares SOHO 2024 Data On CLL
On this episode of "The HemOnc Pulse," Mazyar Shadman, MD, MPH, of the Fred Hutchinson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to highlight some of…
The HemOnc PulseDr. Bose on MPN Highlights From SOHO 2024
On this episode of "The HemOnc Pulse," Prithviraj Bose, MD, of the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss…
The HemOnc PulsePart Two: The Question of MRD in CLL Therapy
In part two of this episode, Mazyar Shadman, MD, MPH, of Fred Hutchinson Cancer Center; Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center; and…
The HemOnc PulseDr. Osman on Identifying and Treating High-Risk MDS
On “The HemOnc Pulse,” Chadi Nabhan, MD, MBA, FACP, met with Afaf Osman, MD, an Assistant Professor at the University of Utah Huntsman Cancer Center, to…
The HemOnc PulseDr. Rami Komrokji on Trends in Real-World MDS Care
On “The HemOnc Pulse,” Chadi Nabhan, MD, MBA, FACP, spoke with Rami Komrokji, MD, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center in…
The HemOnc PulsePart One: The Question of MRD in CLL Therapy
Part one of this episode explores questions in measurable residual disease (MRD) and chronic lymphocytic leukemia (CLL) with Mazyar Shadman, MD, MPH, of Fred…
The HemOnc Pulse‘The HemOnc Pulse’ Live: Unanswered Questions in T-Cell Lymphoma
At the “HemOnc Pulse” Live meeting in Chicago, an expert panel explores unanswered questions in T-cell lymphoma management. The panelists were Mehdi Hamadani…
The HemOnc Pulse‘The HemOnc Pulse’ Live 2024: Is it Time for New Endpoints in MPN?
Recorded at the first annual “HemOnc Pulse” Live meeting, this episode features a panel discussion on unanswered questions in myeloproliferative neoplasms…
The HemOnc PulseUnpacking Bispecifics at ‘The HemOnc Pulse’ Live Meeting
“The HemOnc Pulse” was live for the first time in Chicago, Illinois, on May 3-4 and featured host Chadi Nabhan, MD, MBA, FACP, moderating panels of academic…
The HemOnc Pulse'The HemOnc Pulse' Live: Unanswered Questions in Treating DLBCL
In this podcast episode covering the “HemOnc Pulse” Live meeting in Chicago, an expert panel explores unanswered questions in managing diffuse large B-cell…
The HemOnc Pulse‘The HemOnc Pulse’ Live 2024: Unanswered Questions in CML Treatment
Recorded at the first “HemOnc Pulse” Live meeting in Chicago, this podcast episode features a panel discussion on unanswered questions in chronic myeloid…
The HemOnc Pulse‘The HemOnc Pulse’ Live: What Are the Unanswered Questions in ALL?
Recorded at the first “HemOnc Pulse” annual meeting, this podcast episode features a panel discussion on unanswered questions in acute lymphoblastic leukemia…
The HemOnc PulseDiscussing the Role of MRD in CLL With Talal Hilal, MD
Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates…
The HemOnc Pulse‘The HemOnc Pulse’ Live 2024: How Is Hodgkin Lymphoma Treated?
Recorded at the first “HemOnc Pulse” Live meeting, this podcast episode features a panel discussion on unanswered questions in Hodgkin lymphoma with Andrew…
The HemOnc PulseUnanswered Questions in MDS at ‘The HemOnc Pulse’ Live 2024 in Chicago
Recorded at the first “HemOnc Pulse” Live meeting, this podcast episode features a panel discussion on unanswered questions in myelodysplastic syndromes (MDS)…
The HemOnc Pulse‘The HemOnc Pulse Live’ in Chicago: Fellows Discuss Choosing a Career Path in Hematology Oncology
This podcast episode features a panel discussion on challenges and opportunities for hematology oncology fellows with Megan Melody, MD, a third-year fellow at…
The HemOnc Pulse“The HemOnc Pulse” Live 2024 in Chicago: CAR-T Unanswered Questions
“The HemOnc Pulse” goes on the road to Chicago May 3-4 with host Chadi Nabhan, MD, MBA, FACP, for the first live meeting. This podcast episode features a panel…
The HemOnc Pulse"The HemOnc Pulse" Live 2024 in Chicago: AML Unanswered Questions
"The HemOnc Pulse" goes on the road to Chicago with host Chadi Nabhan, MD, MBA, FACP. This podcast episode features a panel discussion on unanswered questions…
The HemOnc PulseWhat are the Controversies Surrounding MRD in Blood Cancers?
On this episode of "The HemOnc Pulse," Alan Skarbnik, MD, of Novant Health, and Manni Mohyuddin, MBBS, of the University of Utah, discuss the concept of…
The HemOnc PulseHMAs Are ‘Cornerstone’ of High-Risk MDS Treatment, Says Jamile Shammo, MD
On this episode of “The HemOnc Pulse,” Dr. Shammo, a Professor of Medicine in Hematology and Oncology at Northwestern Medicine, discusses how to approach…
The HemOnc PulseKrish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL
Dr. Patel, of the Swedish Cancer Institute in Seattle, Washington, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss novel frontline…
The HemOnc PulseAaron Goodman, MD, Tells Us the 'Crux' of Castleman Disease
In this episode of "The HemOnc Pulse," Dr. Goodman, an Associate Professor of Medicine at the University of California San Diego, joins Chadi Nabhan, MD, MBA…
The HemOnc PulseIs MRD Negativity the New Benchmark in ALL Treatment Strategies?
Elias Jabbour, MD, an Executive Editor of Blood Cancers Today and a Professor of Leukemia at the University of Texas MD Anderson Cancer Center, joins Chadi…
The HemOnc PulsePart Two: Drs. Dahiya, Spiegel Return to Discuss 'Black Box' Warning on CAR-T Therapies
Saurabh Dahiya, MD, FACP, of Stanford Medicine, and Jay Spiegel, MD, of the University of Miami, join The HemOnc Pulse for the second half of a two-part series…
The HemOnc PulseDr. Coombs Spotlights Recent CHIP Updates
In this season's fourth episode of "The HemOnc Pulse," Catherine Coombs, MD, an Associate Professor in the Division of Hematology/Oncology at the University of…
The HemOnc PulseDrs. Dahiya, Spiegel Discuss CAR-T Secondary Malignancies Risk
An all-new episode of The HemOnc Pulse with Saurabh Dahiya, MD, FACP, of Stanford Medicine, and Jay Spiegel, MD, of the University of Miami, features a…
The HemOnc PulseAditi Shastri, MD: Clinicians Need to ‘Come Together’ on TP53-Mutated MDS
This episode features a conversation between Dr. Shastri, an Assistant Professor of Medicine at the Montefiore Einstein Comprehensive Cancer Center in the…